Mode
Text Size
Log in / Sign up
N/A N=113 Randomized Triple-blind Other

Effect of Infant Formula on Energy Balance

Development

Enrolled (actual)
113
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcome: Primary: Growth, Weight for Length (WLZ) Z Scores — -0.26; -0.12; -0.12; 0.13 Z score — p=<0.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Type of Formula (Other)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
Monell Chemical Senses Center
Primary completion
Mar 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Growth, Weight for Length (WLZ) Z Scores
-0.26; -0.12; -0.12; 0.13; 0.24; -0.17 <0.05 sig
PRIMARY
Growth, Weight for Age (WAZ) Z Score
-0.36; -0.25; -0.41; -0.28; -0.38; -0.61 0.001 sig
PRIMARY
Growth: Length for Age (LAZ) Z Scores
-0.49; -0.46; -0.56; 0.59; -0.55; -0.48 0.32
PRIMARY
Energy Balance: Energy Intake From Infant Formula and Other Sources
466; 383; 0; 0; 628; 596 <0.05 sig
PRIMARY
Energy Balance: Sleeping Energy Expenditure (SEE)
206; 201; 329; 321; 507; 509 0.72
PRIMARY
Energy Balance: Total Energy Expenditure (TEE)
283; 243; 488; 444; 859; 858 0.72
PRIMARY
Energy Balance: Energy Loss in Stools
22.3; 34.9; 20.7; 17.0; 27.1; 33.8 0.02 sig
SECONDARY
Feeding Behaviors, Maternal Perceptions
3.1; 3.0; 2.8; 2.6; 2.2; 2.4

Summary

The overarching goal of the research we propose here is to conduct a randomized clinical trial to specify the physiologic and behavioral mechanisms by which infant-formula composition affects all aspects of energy balance and growth during the first years of life.

Eligibility Criteria

Inclusion Criteria

  • A healthy, term (≥37 and ≤42 week gestation at birth), singleton infant.
  • Birth weight between 2500 - 4500 grams.
  • At the time of enrollment, infant must be ≤14 days old (Date of birth=day 0).
  • Mother must be 18 years or older.
  • Infant must be consuming a standard cow's milk protein infant formula and have been receiving a standard cow's milk protein infant formula for at least the past 2 days prior to enrollment.

Exclusion Criteria

  • Mother had gestational diabetes during pregnancy
  • Infant has condition requiring infant feedings other than feeding cow milk formula from a bottle.
  • Infant has major congenital malformations (i.e. cleft palate, hemangiomas, extremity malformation).
  • Infant has suspected or documented systemic or congenital infections (e.g., human immunodeficiency virus, cytomegalovirus).
  • Infant has evidence of significant cardiac, respiratory, endocrinologic, hematologic, gastrointestinal, or other systemic diseases. For example, infant must not be receiving insulin or growth hormone.
  • Dyad be the relative (son, daughter, niece, nephew, cousin, aunt, uncle, sibling) of ancillary personnel connected with the study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01700205). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search